ANDA 80519, held by ALRA. Diphenhydramine Hydrochloride.
As of Nov 22, 2026, ANDA 80519 (Diphenhydramine Hydrochloride), held by ALRA, was first approved by FDA on May 31, 1972, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1972 | Original application | Approved | None posted |
| Diphenhydramine Hydrochloride50MG · capsule;oral | Diphenhydramine Hydrochloride | Discontinued |
| Diphenhydramine Hydrochloride25MG · capsule;oral | Diphenhydramine Hydrochloride | Discontinued |
| Aug 23, 1982 | Supplement 18Manufacturing | Approved | None posted |
| May 31, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters